These findings suggest that CB2 may serve as a key modulator of iron metabolism in IBD macrophages, proposing a novel mechanism to counteract inflammation in pediatric IBD while also reinforcing our previous work. This evidence concerns the gene CNR2 and inflammatory bowel disease.